Absence of gaseous symptoms during ingestion of commercial fibre preparations.
about
Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence.Dietary fiber supplementation for fecal incontinence: a randomized clinical trial.Evidence-Based Approach to Fiber Supplements and Clinically Meaningful Health Benefits, Part 2: What to Look for and How to Recommend an Effective Fiber Therapy.An investigation of fecal volatile organic metabolites in irritable bowel syndrome.Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.Viscous versus nonviscous soluble fiber supplements: mechanisms and evidence for fiber-specific health benefits.Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.Clinical data support that psyllium is not fermented in the gut.Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease.
P2860
Q33450352-2B444048-DE97-4C6E-B06F-B532EF2547CEQ34977360-72C04064-4354-44EC-88C7-603452FFFE3CQ35558326-756D44B8-711B-467B-91B3-B992C9F595FCQ36680897-1B6A084F-D3F9-44FC-BB32-B91D256F231BQ37303691-053D0D7D-DFB1-4254-BC74-AFF79E3AE4F9Q38030572-2774C777-D668-418B-9C6B-D2D90313FDB3Q40066779-05CEDE3C-5473-4200-9577-D4F56E3EBA94Q43897596-88983722-5F63-434B-9AB4-6464117F7C46Q50193587-81E68217-9E48-4B17-9B21-9BFD0A6E3F8AQ53114129-FC20F824-8374-4DE1-867F-4DBF5BA69B8B
P2860
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@ast
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@en
type
label
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@ast
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@en
prefLabel
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@ast
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@en
P2093
P1476
Absence of gaseous symptoms during ingestion of commercial fibre preparations.
@en
P2093
P304
P356
10.1046/J.1365-2036.1997.00250.X
P407
P577
1997-12-01T00:00:00Z